← back to search
Linda Fredrick
AbbVie (United States) · US
Area of research
Infectious Diseases · Hepatology
Research interest
Research interests include Medicine, Ombitasvir, Dasabuvir, Paritaprevir, Ritonavir, and Internal medicine.
h-index
—
citations
313
works
2
NIH funding
—
primary concept
—
email
✉ Find email ↗
Recent publications
Efficacy and safety of glecaprevir/pibrentasvir in patients with HCV genotype 5/6: An integrated analysis of phase 2/3 studies
Liver International
2020
cited by
8
position: middle
doi
Ombitasvir, Paritaprevir Co-dosed With Ritonavir, Dasabuvir, and Ribavirin for Hepatitis C in Patients Co-infected With HIV-1
JAMA
2015
cited by
305
position: middle
doi
Grants
No grants ingested yet.
Frequent collaborators
Gretja Schnell
· AbbVie (United States)
2
papers (2015–2020)
Thomas Podsadecki
· AbbVie (United States)
1
papers (2015–2015)
—
·
1
papers (2015–2015)
Barbara Da Silva‐Tillmann
· AbbVie (United States)
1
papers (2015–2015)
Joseph J. Eron
· University of North Carolina at Chapel Hill
1
papers (2015–2015)
C Wendy Spearman
· University of Cape Town
1
papers (2020–2020)
Barbara McGovern
· Seres Therapeutics (United States)
1
papers (2015–2015)
Richard Elion
· George Washington University
1
papers (2015–2015)
Roger Trinh
· AbbVie (United States)
1
papers (2015–2015)
Paul Y. Kwo
· Palo Alto University
1
papers (2020–2020)
Rakesh Tripathi
· AbbVie (United States)
1
papers (2015–2015)
Yiran Hu
· Wenzhou Medical University
1
papers (2015–2015)
Fred Poordad
· The University of Texas Health Science Center at Houston
1
papers (2020–2020)
Samuel S. Lee
· University of Calgary
1
papers (2020–2020)
—
·
1
papers (2020–2020)
Andrew Campbell
· AbbVie (United States)
1
papers (2015–2015)
Mark Sulkowski
· Johns Hopkins Bayview Medical Center
1
papers (2015–2015)
Federico Mensa
· BioNTech (Germany)
1
papers (2020–2020)
—
·
1
papers (2020–2020)
—
·
1
papers (2015–2015)